Research News – Personalized Cellular Immunotherapies 

We are excited to learn that Kite Pharma announced yesterday they will initiate personalized cellular immunotherapies before the end of 2016. These therapies will target certain sub-segments of the KRAS-mutant cancer patient population (KRAS-mutations are a biomarker of colorectal cancer). This new technology will use living immune cells as the…

Read Full Post

Highlights from the Hill – July 2016

Fight CRC’s D.C.-based policy strategist Margaret Carvin meets year-round with members of Congress and coalition partners to make sure your voice is heard. Highlights from the Hill is a monthly column featuring important meetings she’s attended and detailed information on high -priority issues. Her meetings…

Read Full Post

What the Government Shutdown Means for Colorectal Cancer

After 15 days, most of us have seen at least one way the government shutdown is impacting our country. Some have friends and family members on furlough who’ve finally had time to paint their bathrooms. Others’ vacation plans are ruined since national monuments and parks…

Read Full Post

Advocates in Research Working Group Recommendations

By Nancy Roach, the Founder of C3 and Chair of its Board of Directors A National Cancer Institute (NCI) working group has developed recommendations about how to engage advocates effectively in NCI research activities.  The recommendations are open to public comment until November 30, 2009. …

Read Full Post

Colorectal Cancer Research and Economic Recovery

The American Recovery and Reinvestment Act of 2009 (ARRA) is helping to pay for critically needed colorectal cancer research. In return, scientists and their support staff are hired or kept working, new equipment and supplies are purchased, and local communities benefit economically. As of July…

Read Full Post

Online Tool Predicts Individual Colorectal Cancer Risk

Average risk men and women and their doctors can estimate the probability of that individual developing colon or rectal cancer by using an interactive tool available online.  Developed by National Cancer Institute, the model is based on population research and cancer incidence information. In developing…

Read Full Post

New NCI Designated Cancer Center at University of Maryland

The Marlene and Stewart Greenebaum Cancer Center at the University of Maryland is the newest National Cancer Institute Designated Cancer Center.  NCI has named just 64 centers across the United States as NCI Cancer Centers in recognition of their research excellence and outstanding patient care.

Read Full Post